
Sr. Regulatory Affairs Manager

職位描述
1. Develop and implement registration plan for new products in China within relevant therapeutic areas.
2.Manage registration submissions for new products registration and clinical trial applications.
3.Manage registration submissions for license renewal and variations of marketed products and ensure optimal regulatory support to product lifecycle management for business objectives.
4. Ensure successful implementation of Regulatory Affairs and high quality of filing dossier.
5. Establish and maintain direct contact with European / regional regulatory team for information sharing and ensuring timely support.
6. Undertake interactions and negotiations with Regulatory Authorities to optimize regulatory approvals.
7.Closely follow up regulation changes and analyze/predict its impact on company registration strategies.
8. Keep RA Head informed for the progress of regulatory projects, identify and discuss critical issues and potential solutions before implementation.
9. Contribute to company systems development, support China RA team to develop or enhance regulatory related SOPs, management systems, working procedures, etc. to improve team operational efficiency.
任職要求:
1. Profound knowledge of pharmaceutical business, worldwide drug development and regulatory processes, expertise of international and national regulatory guidelines.
2.Ability to effectively manage interactions with internal and external stakeholders for ensuring optimal cooperation.
3.Understanding of market access needs and implementation of appropriate measures for health care purposes.
4. Strong interpersonal skills and ability to interface effectively with company local relevant functions and global regulatory team.
5. Ability to anticipate and facilitate issue resolution to meet local registration requirements.
6.High leadership skills with both practical and short/long term strategic vision; ability to build relationships; strong team leader as well as team player.
7.Demonstrates and encourages ownership and responsibility; drive/motivation - has a “can-do” attitude and is committed to delivering high quality results and strives for continuous improvement.
8. A good blend of strategic and analytical thinking; innovative personality; able to see the bigger picture.
企業(yè)簡介
1993年4月,經(jīng)衛(wèi)生部和國家醫(yī)藥局批準(zhǔn),在北京人民大會堂由北京制藥廠與萌蒂國際集團共同投資簽約成立,成為國內(nèi)首家以生產(chǎn)及銷售控緩釋劑型為主的特殊鎮(zhèn)痛藥品的中外合資企業(yè)。
2006年10月,購買股份成為獨資公司。2010年投資兩千萬美元在中關(guān)村科技園通州園金橋科技產(chǎn)業(yè)基地,建造世界一流的新工廠,2010年5月正式更名為:萌蒂(中國)制藥有限公司。
萌蒂(中國)制藥有限公司是國家定點的麻醉鎮(zhèn)痛藥品生產(chǎn)單位之一。公司擁有高度自動化的特殊片劑生產(chǎn)線,采用萌蒂國際集團所屬的英國NAPP公司的世界一流控釋技術(shù),并嚴格按照GMP標(biāo)準(zhǔn),生產(chǎn)的鎮(zhèn)痛藥品覆蓋了癌癥三階梯鎮(zhèn)痛方案中的每個階梯。如美施康定(硫酸嗎啡控釋片)、奧施康定(鹽酸羥考酮控釋片)、奇曼丁(鹽酸曲馬多緩釋片)、意施?。ㄟ胚崦佬量蒯屍┑?。癌癥三階梯鎮(zhèn)痛方案由世界衛(wèi)生組織推薦,并在全世界范圍內(nèi)被廣泛應(yīng)用。
萌蒂國際集團在全世界范圍內(nèi)擁有100多家麻醉鎮(zhèn)痛藥生產(chǎn)企業(yè)及分支機構(gòu),是世界上最大的獨營制藥企業(yè)。萌蒂國際集團的創(chuàng)始人——賽克勒博士在抗日戰(zhàn)爭時期就曾資助白求恩大夫來到中國。新中國成立以后,賽克勒博士贊助了第一屆國際營養(yǎng)學(xué)會的召開,并與中國衛(wèi)生部合作創(chuàng)辦了《中國醫(yī)學(xué)論壇報》,同時設(shè)立了優(yōu)秀醫(yī)師年度獎,捐資修建了北京大學(xué)賽克勒考古藝術(shù)博物館,還在2008年5月15日積極響應(yīng)溫家寶總理的號召,通過全國紅十字會向災(zāi)區(qū)捐獻價值50萬人民幣的鎮(zhèn)痛藥-奇曼丁,用于救治災(zāi)區(qū)人民,減輕受傷群眾的疼痛。同時,萌蒂公司的員工也自發(fā)地向地震災(zāi)區(qū)捐款,希望為抗災(zāi)、救災(zāi)貢獻自己的一份綿力,幫助災(zāi)區(qū)人民渡過難關(guān),重建家園。
職位發(fā)布企業(yè)

萌蒂(中國)制藥有限公司
企業(yè)性質(zhì):合資企業(yè)
企業(yè)規(guī)模:1000-1999人
成立年份:1993
企業(yè)網(wǎng)址:www.mundipharma.co.uk
企業(yè)地址:北京
該企業(yè)其他職位更多>>
相關(guān)職位推薦
北京相關(guān)職位: 工程師(醫(yī)療售后)
熱門區(qū)域招聘: 重慶 北京 上海 浙江 江蘇 廣東 山東 湖南 安徽 河北
北京招聘企業(yè): 寶日醫(yī)生物技術(shù)(北京)有限公司 叮當(dāng)智慧藥房(北京)有限公司 北京久峰潤達生物技術(shù)有限公司 北京協(xié)和醫(yī)院 北京海斯美醫(yī)藥技術(shù)有限公司 北京策知易咨詢有限公司 北京萬泰生物藥業(yè)有限公司 百濟神州 北京凱霖娜國際貿(mào)易有限公司好益生醫(yī)院分公司 中國生物制藥有限公司
職位發(fā)布日期: 2019-05-28